|
1
|
Colon NC and Chung DH: Neuroblastoma. Adv
Pediatr. 58:297–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matthay KK, George RE and Yu AL: Promising
therapeutic targets in neuroblastoma. Clin Cancer Res.
18:2740–2753. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reiter JL and Brodeur GM: High-resolution
mapping of a 130-kb core region of the MYCN amplicon in
neuroblastomas. Genomics. 32:97–103. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matthay KK, Villablanca JG, Seeger RC,
Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT,
Brodeur GM, et al; Children’s Cancer Group. Treatment of high-risk
neuroblastoma with intensive chemotherapy, radiotherapy, autologous
bone marrow transplantation, and 13-cis-retinoic acid. N Engl J
Med. 341:1165–1173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knoepfler PS, Cheng PF and Eisenman RN:
N-myc is essential during neurogenesis for the rapid expansion of
progenitor cell populations and the inhibition of neuronal
differentiation. Genes Dev. 16:2699–2712. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang M and Weiss WA: Neuroblastoma and
MYCN. Cold Spring Harb Perspect Med. 3:a0144152013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu PY, Erriquez D, Marshall GM, Tee AE,
Polly P, Wong M, Liu B, Bell JL, Zhang XD, Milazzo G, et al:
Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc
expression and neuroblastoma progression. J Natl Cancer Inst.
106:dju1132014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suenaga Y, Islam SM, Alagu J, Kaneko Y,
Kato M, Tanaka Y, Kawana H, Hossain S, Matsumoto D, Yamamoto M, et
al: NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved
protein that inhibits GSK3β resulting in the stabilization of MYCN
in human neuroblastomas. PLoS Genet. 10:e10039962014. View Article : Google Scholar
|
|
16
|
Shoji W, Suenaga Y, Kaneko Y, Islam SM,
Alagu J, Yokoi S, Nio M and Nakagawara A: NCYM promotes
calpain-mediated Myc-nick production in human MYCN-amplified
neuroblastoma cells. Biochem Biophys Res Commun. 461:501–506. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shahbazi J, Liu PY, Atmadibrata B, Bradner
JE, Marshall GM, Lock RB and Liu T: The bromodomain inhibitor JQ1
and the histone deacetylase inhibitor panobinostat synergistically
reduce N-Myc expression and induce anticancer effects. Clin Cancer
Res. 22:2534–2544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu PY, Xu N, Malyukova A, Scarlett CJ,
Sun YT, Zhang XD, Ling D, Su SP, Nelson C, Chang DK, et al: The
histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death
Differ. 20:503–514. 2013. View Article : Google Scholar :
|
|
19
|
Tee AE, Liu B, Song R, Li J, Pasquier E,
Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, et al: The
long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by
up-regulating pro-angiogenic gene expression. Oncotarget.
7:8663–8675. 2016.PubMed/NCBI
|
|
20
|
Liu T, Liu PY, Tee AEL, Haber M, Norris
MD, Gleave ME and Marshall GM: Over-expression of clusterin is a
resistance factor to the anti-cancer effect of histone deacetylase
inhibitors. Eur J Cancer. 45:1846–1854. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kocak H, Ackermann S, Hero B, Kahlert Y,
Oberthuer A, Juraeva D, Roels F, Theissen J, Westermann F, Deubzer
H, et al: Hox-C9 activates the intrinsic pathway of apoptosis and
is associated with spontaneous regression in neuroblastoma. Cell
Death Dis. 4:e5862013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oberthuer A, Juraeva D, Li L, Kahlert Y,
Westermann F, Eils R, Berthold F, Shi L, Wolfinger RD, Fischer M,
et al: Comparison of performance of one-color and two-color
gene-expression analyses in predicting clinical endpoints of
neuroblastoma patients. Pharmacogenomics J. 10:258–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaplan EL and Meier P: Nonparametric
estimation from incomplete observations. Breakthroughs in
Statistics. Kotz S and Johnson N: Springer; New York, NY: pp.
319–337. 1992, View Article : Google Scholar
|
|
24
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wyce A, Ganji G, Smitheman KN, Chung CW,
Korenchuk S, Bai Y, Barbash O, Le B, Craggs PD, McCabe MT, et al:
BET inhibition silences expression of MYCN and BCL2 and induces
cytotoxicity in neuroblastoma tumor models. PLoS One. 8:e729672013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puissant A, Frumm SM, Alexe G, Bassil CF,
Qi J, Chanthery YH, Nekritz EA, Zeid R, Gustafson WC, Greninger P,
et al: Targeting MYCN in neuroblastoma by BET bromodomain
inhibition. Cancer Discov. 3:308–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanchez R and Zhou MM: The role of human
bromodomains in chromatin biology and gene transcription. Curr Opin
Drug Discov Devel. 12:659–665. 2009.PubMed/NCBI
|
